Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Res Notes ; 11(1): 863, 2018 Dec 05.
Article in English | MEDLINE | ID: mdl-30518414

ABSTRACT

OBJECTIVE: The advent of ligand-based receptor capture methodologies, allows the identification of unknown receptor candidates for orphan extracellular ligands. However, further target validation can be tedious, laborious and time-consuming. Here, we present a methodology that provides a fast and cost-efficient alternative for candidate target verification on living cells. RESULTS: In the described methodology a ligand of interest (e.g. transferrin, epidermal growth factor or insulin) was conjugated to a linker (TriCEPS) that carries a biotin. To confirm ligand/receptor interactions, the ligand-TriCEPS conjugates were first added onto living cells and cells were subsequently labeled with a streptavidin-fluorophore and analyzed by flow cytometry (thus referred as Flow-TriCEPS). Flow-TriCEPS was also used to validate identified receptor candidates when combined with a siRNA knock down approach (i.e. reduction of expression levels). This approach is versatile as it can be applied for different classes of ligands (proteins, peptides, antibodies) and different cell lines. Moreover, the method is time-efficient since it takes advantage of the large variety of commercially available (and certified) siRNAs.


Subject(s)
Biotin/analogs & derivatives , ErbB Receptors/metabolism , Flow Cytometry/methods , Hydrazines/metabolism , Succinimides/metabolism , Biotin/metabolism , Cell Line, Tumor , HEK293 Cells , Humans , Insulin/metabolism , Ligands , RNA, Small Interfering/metabolism , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL
...